Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F
Jilin, China, May 23, 2025 (GLOBE NEWSWIRE) — Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the 'Company' or 'Zhengye'), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in China, today announced that it has received a letter from the NASDAQ Stock Market, dated May 20, 2025 (the 'Delinquency Letter'), notifying the Company that it is not in compliance with the requirements for continued listing set forth in NASDAQ Listing Rule 5250(c)(1) because it did not timely file its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the '2024 Annual Report').
In accordance with NASDAQ Listing Rules, the Company has 60 calendar days from the date of the Delinquency Letter to submit a plan to regain compliance with NASDAQ Listing Rules (the 'Compliance Plan'). If NASDAQ accepts the Compliance Plan, NASDAQ may grant the Company an extension of up to 180 calendar days from the Company's Form 20-F filing due date, or until November 11, 2025, to regain compliance. The Company intends to submit the Compliance Plan within the prescribed 60-day period.
The Delinquency Letter has no immediate impact on the listing of the Company's ordinary shares on the Nasdaq Capital Market.
This announcement is made in compliance with NASDAQ Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.
About Zhengye Biotechnology Holding Limited
Through Jilin Zhengye Biological Products Co., Ltd., the Company's operating entity based in Jilin, China, Zhengye Biotechnology Holding Limited focuses on the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. For over 20 years, the operating entity has been committed to enhancing the health of animals. The operating entity has 44 veterinary vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The operating entity's products are available in 28 provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The operating entity has three GMP veterinary vaccine production floors, including 13 GMP vaccine production lines, one quality examination center, and one animal facility for vaccine development. The operating entity has 49 employees who have over a decade of experience in the veterinary vaccine industry. For more information, please visit the Company's website: http://ir.jlzybio.com.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as 'approximates,' 'believes,' 'hopes,' 'expects,' 'anticipates,' 'estimates,' 'projects,' 'intends,' 'plans,' 'will,' 'would,' 'should,' 'could,' 'may' or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and other filings with the SEC.
For more information, please contact:
Zhengye Biotechnology Holding Limited Investor Relations Department
Email: [email protected]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Personas Announces Change of Trading Symbol to Keek on the TSXV
TORONTO, ON / / June 5, 2025 / Personas Social Incorporated (the "Company") (TSXV:KEEK) is pleased to announce that, effective at the opening of trading on or about June 9, 2025, the Company's common shares will trade on the TSX Venture Exchange ("TSXV") under the new trading symbol "KEEK". The change in the Company's trading symbol from "PRSN" to "KEEK" follows the Company's strategic rebranding initiative to focus on the continued roll out of the Company's new Keek's social platform. There is no change in the capitalization of the Company, and shareholders are not required to take any action regarding the change. The transfer agent of the Company continues to be TSX Trust Company. Outstanding common shares certificates or a DRS advice does not need to be exchanged. If registered shareholders have any questions or wish to receive an updated DRS advice or share certificate, they can contact the Company's transfer agent directly at, TSX Trust Company Investor Services by calling toll free 1-866-600-5869, or by email at tsxtis@ or by visiting About Personas Personas Social Incorporated is a Canada-based company engaged in the business of offering live video conferencing technology, live streaming, social media products and services for use by consumers and businesses, with a focus on mobile (iOS and Android) products. It focuses on providing social commerce-enabled products which allow for a monetizable user experience to all users, consumers and businesses alike. The Company accomplishes this by offering products which are complete with enterprise-grade e-commerce infrastructure including multi-currency, multi-lingual, turnkey mobile commerce suites for users. For further information, please contact: Personas Social IncorporatedMark Itwaru Chairman & Chief Executive Officer Phone: 647.789.0074 Email: mark@ Forward Looking Statements This press release contains statements that constitute "forward-looking statements". Such forward looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance or achievements, or developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. When used in this press release, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. The forward-looking statements and information in this press release include: the stock symbol change and certain related corporate matters. Such statements and information reflect the current view of the Company. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release represent the expectations of the Company as of the date of this news release and, accordingly, are subject to change after such date. Readers should not place undue importance on forward-looking statements and should not rely upon this information as of any other date. The Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has reviewed or accepts responsibility for the adequacy or accuracy of this Release. SOURCE: Personas Social Incorporated View the original press release on ACCESS Newswire Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
NVIDIA (NasdaqGS:NVDA) Collaborates With Accenture And AdaCore For AI And Automotive Innovation
NVIDIA has gained attention with its recent expansion in AI startups and introduction of new programming languages for the automotive market, coinciding with a 28% share price increase in the last quarter. These developments align with the broader market's modest upward trend, as the S&P 500 and Nasdaq both marked winning streaks, lifted by renewed economic optimism and progress in trade talks with China. NVIDIA's collaboration with Accenture, AdaCore, and various industry leaders adds weight to its momentum, complementing its focus on AI and autonomous technology, which have remained key drivers of interest amid robust market conditions. We've spotted 1 possible red flag for NVIDIA you should be aware of. We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. The recent developments at NVIDIA, particularly its expansion into AI startups and new programming languages for the automotive market, could significantly influence its long-term growth narrative. The partnerships with industry giants Toyota and Uber aim to cement NVIDIA's presence in the autonomous vehicles sector, potentially boosting revenue streams and market share. These collaborations align with NVIDIA's focus on AI and autonomous technology, potentially enhancing its data center and AI workloads, which in turn might improve earnings and margin potential. Analysts have projected NVIDIA's earnings to grow substantially, assuming it capitalizes on these burgeoning opportunities. However, regulatory challenges and export controls could impact these forecasts, as uncertainty remains a persistent risk. Over the past five years, NVIDIA's total return, including share price appreciation and dividends, has been very large, reflecting significant long-term value creation. In comparison to its one-year performance, NVIDIA surpassed the US Semiconductor industry, which posted a 10.3% gain, suggesting strong relative performance. This longer-term gain is a testament to NVIDIA's rapid growth trajectory, bolstered by innovation and strategic sector expansions. Despite the impressive gains, NVIDIA's current share price of US$113.54 is significantly lower than the consensus analyst price target of US$163.12, indicating potential room for growth. As the company continues to navigate AI and automotive sectors, these market moves can be pivotal in driving future revenue and earnings. Investors may need to assess if the growth potential justifies the price target, considering the associated risks and market dynamics. The ongoing scaling of the Blackwell architecture and its implications for operational efficiency and cost management will be central to NVIDIA meeting or exceeding analyst expectations. Assess NVIDIA's future earnings estimates with our detailed growth reports. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:NVDA. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Pentagon Wants To Shift Funds From Navy F/A-XX To USAF F-47: Report
The U.S. Navy's F/A-XX sixth-generation fighter program looks to have hit another snag, with the Pentagon reportedly prioritizing the Air Force's F-47 stealth fighter, amid concerns about how to run the two efforts simultaneously. Already, the F/A-XX was in limbo, with a U.S. official telling TWZ last month that the future of the program was still being reviewed. This came after reports that a contract award for the Navy's new combat jet could be delayed by as much as three years. Navy officials, meanwhile, continue to stress the importance of the F/A-XX to their plans. 'There's certainly a strong requirement for a sixth-gen fighter still,' Dr. Brett A. Seidle, Acting Assistant Secretary of the Navy for Research, Development, and Acquisition (RD&A), said yesterday. 'I know there's a lot of discussion about [F/A-XX] right now, but the Navy position on that is there's a requirement that's necessary.' Seidle was speaking at a House Armed Services Committee hearing on Seapower and Projection Forces. His comments came in response to questions from U.S. Rep. Joseph David Courtney, the Democrat representative for Connecticut's 2nd congressional district. You can see that exchange in the video below, starting at the 35.25 mark: The hearing followed a Pentagon request last month to the House and Senate defense policy committees, which was seen by Bloomberg News, warning that 'Simultaneously pursuing two sixth-generation fighters risks under-delivery on both.' 'Given the schedule delays and cost growth across numerous airframes, DoD recommends a focus on the F-47, giving the Navy's F/A-XX program time for technical maturity and development,' the Pentagon request added. 'Phasing the F/A-XX after the Air Force's initial F-47 development will alleviate capacity concerns in the industrial base.' Exactly why there should be concerns about industrial capacity is somewhat unclear, although that could be a factor were Boeing to win the F/A-XX contract on top of the F-47. On the other hand, with Northrop Grumman busy with the B-21 stealth bomber, which still needs to get through flight testing, adding a few years to the F/A-XX timeline could mitigate risk there, were this contractor to walk away with F/A-XX. Reportedly, the U.S. Department of Defense requested that Congress shift $500 million from F/A-XX to the F-47, the contract for which was awarded to Boeing in March. Previously, these funds were allocated for the 'accelerated development' of the Navy fighter. There is now something of a battle between the Pentagon Secretary of Defense Pete Hegseth and the House Armed Services Committee (HASC). On the one hand, the F-47 is considered by the Pentagon to have 'full presidential support,' making it a priority for the $500 million that the House Armed Services Committee had added to the F/A-XX program under President Donald Trump's sweeping $3.9-trillion tax breaks package. While we previously reported on Pentagon recommendations to withhold $500 million from the F/A-XX program, it wasn't previously understood that it wanted to redirect this to the Air Force's equivalent effort, the F-47. The House Armed Services Committee is now seeking to block the funds from being redirected to the F-47, arguing that the Pentagon hasn't provided an adequate reason for this. Heather Vaughan, a committee spokesperson, told Bloomberg News that the Pentagon 'has yet to brief the committee on any changes for its plans to develop and procure' the Navy's new stealth jet. 'Absent any new information from the Navy concerning revision to defined capability gaps and shortfalls, mission requirements, cost, or acquisition strategy for F/A-XX, the committee continues to support the development of this critical platform,' Vaughan added. Earlier this week, the Senate Armed Services Committee released its defense section of the tax breaks package, which includes $750 million to 'accelerate the F/A-XX aircraft.' Originally, Boeing, Lockheed Martin, and Northrop Grumman were all in the running to develop the F/A-XX. However, Lockheed Martin was reportedly eliminated from the competition in March because its proposal 'did not satisfy the service's criteria,' according to Breaking Defense, whose story cited an unnamed source with knowledge of the program. Any holdups to the F/A-XX program will be a worry for the Navy. The service considers a sixth-generation combat aircraft as a prerequisite for the future carrier air wing, especially in terms of a potential confrontation with China in the Indo-Pacific theater. 'The sixth-gen fighter has some capabilities that we need to counter the PRC,' Navy Adm. James W. Kilby, acting Chief of Naval Operations, said of the F/A-XX last month. 'Those are signatures, those are range, those are different engines. Those are all the things that will make it survivable. The Air Force and Navy have different missions, but we're going against the same threat.' Last month, a U.S. official, speaking to TWZ on condition of anonymity, denied reports that the F/A-XX program contract award could be delayed by as much as three years. 'Nothing is being delayed,' the official stated. 'A decision hasn't been made yet. That decision is still being determined by [the Pentagon] and service leaders, with conversations among Congress as well. It's a big program. Obviously, these things don't get settled on by one individual. Leaders are making a decision on whether to invest. It's all part of the process.' The Navy had planned for the F/A-XX aircraft to enter service in the 2030s and thereafter to replace F/A-18E/F Super Hornet strike fighters and EA-18G Growler electronic attack jets. According to a 2025 Naval Aviation Playbook, the F/A-XX 'is expected to feature superior range, speed, and sensor capabilities, with an emphasis on integrating manned and unmanned systems. This includes collaboration with autonomous drones serving as force multipliers and electronic warfare assets.' In regards to the range, it emerged earlier this year that the F/A-XX may offer just a 25 percent increase in this respect over the existing tactical combat jets in its carrier air wings. That disclosure is surprising, given that the service consistently makes it clear that extending the reach of its carrier strike groups and thus enhancing their survivability is a critical priority, as the range of expected threats also continues to grow. Regardless, the continued funding dispute may well still derail the current timeline for F/A-XX. In a report last month, Reuters wrote that the Pentagon's main issue about the F/A-XX program was 'concerns about engineering and production capacity,' but didn't elaborate further. If the F/A-XX does end up being delayed, the Navy might well have to look again at its tactical fighter fleet to avoid shortfalls. One immediate result would be the service relying longer than expected on its aging fleets of Super Hornets and Growlers. At one stage, the Super Hornet production line was expected to be shut down this year. However, in March of last year, the Navy issued Boeing a $1.3-billion contract for 17 new Super Hornets with a final delivery planned for spring 2027 at the latest. Buying more Super Hornets could be an option, but such a move would have to be made before the line is closed. An alternative would be to push more resources toward the F-35C stealth fighter, which the Navy has introduced to replace the last of its 'legacy' Hornets. As well as the baseline F-35C, Lockheed Martin is increasingly looking at the potential of further advanced developments of the Joint Strike Fighter, something the company has previously described as a 'Ferrari' or 'NASCAR upgrade' to the F-35's core 'chassis.' This could include a substantial fuselage redesign. With a future Pacific fight very much on its mind, neither of these options would be ideal for the Navy, and the current uncertainty around the F/A-XX program is very much bad news for the service. It's also worth considering the Navy's approach for the fleets of carrier-capable drone wingmen that it wants to accompany crewed combat aircraft in the future. As it now stands, the service wants its Collaborative Combat Aircraft (CCA) designs to cost no more than $15 million to buy and have zero long-term sustainment costs. At the same time, there are signs the Navy may not be moving as quickly on CCAs as the Air Force, as you can read about here. Meanwhile, if the Pentagon gets its way and is able to inject another $500 million into the F-47, that will only help realize its goal to have the next-generation Air Force combat jet flying before the end of the current Trump administration. Contact the author: thomas@
